Publications
TAMI-29. MULTIFACTORIAL UPREGULATION OF ID1 DRIVES DIPG INVASIVENESS AND IS THERAPEUTICALLY TARGETABLE
Nand Yadav, V,
Harris, MK,
Stallard, S,
Woo, R,
Siddaway, R,
Qin, T,
Cummings, J,
Mullan, B,
Miklja, Z,
Siada, R,
Ravindran, R,
Cao, X,
Pasternak, A,
Castro, MG,
Lowenstein, P,
Mody, R,
Chinnaiyan, A,
Hawkins, C,
Desprez, P,
McAllister, S,
Venneti, S,
Koschmann, C,
Neuro-Oncology, 2020 Nov; DOI:10.1093/neuonc/noaa215.917 TAMI-42. H3K27M MUTANT GLIOMAS HIJACK A CONSERVED AND CRITICAL METABOLIC PATHWAY USED BY IDH1 MUTANT GLIOMAS TO MAINTAIN THEIR PREFERRED EPIGENETIC STATE
Chung, C,
Sweha, S,
Pratt, D,
Tamrazi, B,
Panwalkar, P,
Banda, A,
Bayliss, J,
Hawes, D,
Yang, F,
Lee, H-J,
Shan, M,
Cieslik, M,
Qin, T,
Werner, C,
Wahl, D,
Lyssiotis, C,
Yadav, VN,
Koschmann, C,
Chinnaiyan, A,
Blumul, S,
Judkins, A,
Venneti, S,
Neuro-Oncology, 2020 Nov; DOI:10.1093/neuonc/noaa215.930 NIMG-31. NON-DIPG PATIENTS ENROLLED IN THE INTERNATIONAL DIPG REGISTRY: HISTOPATHOLOGIC EVALUATION OF CENTRAL NEURO-IMAGING REVIEW
Lazow, M,
Fuller, C,
Lane, A,
DeWire, M,
Bandopadhayay, P,
Bartels, U,
Bouffet, E,
Cheng, S,
Cohen, KJ,
Cooney, T,
Coven, S,
Dholaria, H,
Diez, B,
Dorris, K,
El-Ayadi, M,
El-Sheikh, A,
Fisher, P,
Lombardi, MG,
Greiner, R,
Goldman, S,
Gottardo, N,
Gururangan, S,
Hansford, J,
Hassall, T,
Hawkins, C,
Kilburn, L,
Koschmann, C,
Leary, S,
Ma, J,
Minturn, J,
Monje, M,
Packer, R,
Samson, Y,
Sandler, ES,
Sevlever, G,
Tinkle, C,
Tsui, K,
Wagner, L,
Zaghloul, M,
Ziegler, D,
Chaney, B,
Black, K,
Asher, A,
Drissi, R,
Fouladi, M,
Jones, B,
Leach, J,
Neuro-Oncology, 2020 Nov; DOI:10.1093/neuonc/noaa215.644 CTNI-15. CLINICAL EFFICACY OF ONC201 IN NEWLY DIAGNOSED DIPG AND IN PREVIOUSLY IRRADIATED PEDIATRIC H3 K27M-MUTANT GLIOMAS
Gardner, S,
Koschmann, C,
Tarapore, RS,
Allen, J,
Zaky, W,
Odia, Y,
Hall, M,
Daghistani, D,
Khatib, Z,
Aguilera, D,
MacDonald, T,
Fouladi, M,
McGovern, S,
Mueller, S,
Kline, C,
Vitanza, N,
Lu, G,
Allen, J,
Khatua, S,
Neuro-Oncology, 2020 Nov; DOI:10.1093/neuonc/noaa215.182 DDRE-03. INTERNATIONAL PRECLINICAL DRUG DISCOVERY AND BIOMARKER PROGRAM INFORMING AN ADOPTIVE COMBINATORIAL TRIAL FOR DIFFUSE MIDLINE GLIOMAS
Przystal, J,
Yadavilli, S,
Abadi, CC,
Yadav, VN,
Laternser, S,
Cosentino, CC,
Waszak, S,
Cartaxo, R,
Biery, M,
Myers, C,
Jayasekara, S,
Olson, J,
Filbin, M,
Vitanza, N,
Cain, J,
Koschmann, C,
Mueller, S,
Nazarian, J,
Neuro-Oncology, 2020 Nov; DOI:10.1093/neuonc/noaa215.248 Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma
Jairath, NK,
Farha, MW,
Jairath, R,
Harms, PW,
Tsoi, LC,
Tejasvi, T,
Melanoma Manag, 2020 Nov; DOI:10.2217/mmt-2020-0019 Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer
Swami, U,
Isaacsson Velho, P,
Nussenzveig, R,
Chipman, J,
Sacristan Santos, V,
Erickson, S,
Dharmaraj, D,
Alva, AS,
Vaishampayan, UN,
Esther, J,
Hahn, AW,
Maughan, BL,
Antonarakis, ES,
Agarwal, N,
Eur Urol, 2020 Nov; DOI:10.1016/j.eururo.2020.06.033 CTNI-17. Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma
Rahman Kawakibi, A,
Tarapore, RS,
Gardner, S,
Thomas, C,
Cartaxo, R,
Yadav, VN,
Chi, A,
Kurz, S,
Wen, P,
Arrillaga-Romany, I,
Batchelor, T,
Butowski, N,
Sumrall, A,
Shonka, N,
Harrison, R,
de Groot, J,
Mehta, M,
Odia, Y,
Hall, M,
Daghistani, D,
Cloughesy, T,
Ellingson, B,
Umemura, Y,
Garton, H,
Franson, A,
Robertson, P,
Schwartz, J,
Cantor, E,
Miklja, Z,
Mullan, B,
Bruzek, A,
Siada, R,
Cummings, J,
Paul, A,
Wolfe, I,
Jiang, L,
Filbin, M,
Vats, P,
Kumar-Sinha, C,
Mody, R,
Chinnaiyan, A,
Venneti, S,
Lu, G,
Mueller, S,
Martinez, D,
Resnick, A,
Nazarian, J,
Waszak, S,
Allen, J,
Koschmann, C,
Neuro-oncology, 2020 Nov; Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice
Lebastchi, AH,
Russell, CM,
Niknafs, YS,
Eyrich, NW,
Chopra, Z,
Botbyl, R,
Kabeer, R,
Osawa, T,
Siddiqui, J,
Siddiqui, R,
Davenport, MS,
Mehra, R,
Tomlins, SA,
Kunju, LP,
Chinnaiyan, AM,
Wei, JT,
Tosoian, JJ,
Morgan, TM,
Urology, 2020 Nov; DOI:10.1016/j.urology.2020.07.042 Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer
Steele, NG,
Carpenter, ES,
Kemp, SB,
Sirihorachai, VR,
The, S,
Delrosario, L,
Lazarus, J,
Amir, E-AD,
Gunchick, V,
Espinoza, C,
Bell, S,
Harris, L,
Lima, F,
Irizarry-Negron, V,
Paglia, D,
Macchia, J,
Chu, AKY,
Schofield, H,
Wamsteker, E-J,
Kwon, R,
Schulman, A,
Prabhu, A,
Law, R,
Sondhi, A,
Yu, J,
Patel, A,
Donahue, K,
Nathan, H,
Cho, C,
Anderson, MA,
Sahai, V,
Lyssiotis, CA,
Zou, W,
Allen, BL,
Rao, A,
Crawford, HC,
Bednar, F,
Frankel, TL,
Pasca di Magliano, M,
Nat Cancer, 2020 Nov; DOI:10.1038/s43018-020-00121-4 Radiologic-pathologic correlation of transvaginal ultrasound and risk-reducing bilateral salpingo-oophorectomy in women at high risk for tubo-ovarian carcinoma.
Sakala, MD,
Curci, NE,
Masch, WR,
Mendiratta-Lala, M,
Stein, EB,
Wasnik, AP,
Sciallis, AP,
Uppal, S,
Pearlman, MD,
Maturen, KE,
Radiol Imaging Cancer, 2020 Nov; DOI:10.1148/rycan.2020190086 Accelerating precision medicine in metastatic prostate cancer
Mateo, J,
McKay, R,
Abida, W,
Aggarwal, R,
Alumkal, J,
Alva, A,
Feng, F,
Gao, X,
Graff, J,
Hussain, M,
Karzai, F,
Montgomery, B,
Oh, W,
Patel, V,
Rathkopf, D,
Rettig, M,
Schultz, N,
Smith, M,
Solit, D,
Sternberg, C,
Van Allen, E,
VanderWeele, D,
Vinson, J,
Soule, HR,
Chinnaiyan, A,
Small, E,
Simons, JW,
Dahut, W,
Miyahira, AK,
Beltran, H,
Nat Cancer, 2020 Nov; DOI:10.1038/s43018-020-00141-0 Invasive Squamous Cell Carcinomas and Precursor Lesions on UV-exposed Epithelia Demonstrate Concordant Genomic Complexity in Driver Genes
Lazo de la Vega, L,
Bick, N,
Hu, K,
Rahrig, SE,
Silva, CD,
Matayoshi, S,
Picciarelli, P,
Wang, X,
Sugar, A,
Soong, HK,
Mian, SI,
Robinson, DR,
Chinnaiyan, AM,
Demirci, H,
Daniels, AB,
Worden, F,
Eberhart, CG,
Tomlins, SA,
Rao, RC,
Harms, PW,
Mod Pathol, 2020 Nov; DOI:10.1038/s41379-020-0571-7 UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer
Liu, Y,
Awadia, S,
Delaney, A,
Sitto, M,
Engelke, CG,
Patel, H,
Calcaterra, A,
Zelenka-Wang, S,
Lee, H,
Contessa, J,
Neamati, N,
Ljungman, M,
Lawrence, TS,
Morgan, MA,
Rehemtulla, A,
Transl Oncol, 2020 Nov; DOI:10.1016/j.tranon.2020.100834 Natural history of hepatocellular carcinoma after stereotactic body radiotherapy.
Mendiratta-Lala, M,
Masch, W,
Owen, D,
Aslam, A,
Maurino, C,
Devasia, T,
Schipper, MJ,
Parikh, ND,
Cuneo, K,
Lawrence, TS,
Davenport, MS,
Abdom Radiol (NY), 2020 Nov; DOI:10.1007/s00261-020-02532-4 The Feasibility and Impact of a Presurgical Exercise Intervention Program (Prehabilitation) for Patients Undergoing Cystectomy for Bladder Cancer.
Kaye, DR,
Schafer, C,
Thelen-Perry, S,
Parker, C,
Iglay-Reger, H,
Daignault-Newton, S,
Qin, Y,
Morgan, TM,
Weizer, AZ,
Kaffenberger, SD,
Herrel, LA,
Hafez, KS,
Lee, CT,
Skolarus, TA,
Englesbe, MJ,
Montgomery, JS,
Urology, 2020 Nov; DOI:10.1016/j.urology.2020.05.104 Breast Reconstruction Practices and Barriers in West Africa: A Survey of Surgeons
Ranganathan, K,
Ogunleye, AA,
Aliu, O,
Agbenorku, P,
Momoh, AO,
Plast Reconstr Surg Glob Open, 2020 Nov; DOI:10.1097/GOX.0000000000003259 Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions.
Aslam, A,
Do, RKG,
Kambadakone, A,
Spieler, B,
Miller, FH,
Gabr, AM,
Charalel, RA,
Kim, CY,
Madoff, DC,
Mendiratta-Lala, M,
World J Hepatol, 2020 Oct; DOI:10.4254/wjh.v12.i10.738 Prognostic significance of oxidation pathway mutations in recurrent laryngeal squamous cell carcinoma
Heft Neal, ME,
Bhangale, AD,
Birkeland, AC,
McHugh, JB,
Shuman, AG,
Rosko, AJ,
Swiecicki, PL,
Spector, ME,
Brenner, JC,
Cancers (Basel), 2020 Oct; DOI:10.3390/cancers12113081 A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer
Zhang, T,
Harrison, MR,
O'Donnell, PH,
Alva, AS,
Hahn, NM,
Appleman, LJ,
Cetnar, J,
Burke, JM,
Fleming, MT,
Milowsky, MI,
Mortazavi, A,
Shore, N,
Sonpavde, GP,
Schmidt, EV,
Bitman, B,
Munugalavadla, V,
Izumi, R,
Patel, P,
Staats, J,
Chan, C,
Weinhold, KJ,
George, DJ,
Cancer, 2020 Oct; DOI:10.1002/cncr.33067 Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs.
Hassani Najafabadi, A,
Zhang, J,
Aikins, ME,
Najaf Abadi, ZI,
Liao, F,
Qin, Y,
Okeke, EB,
Scheetz, LM,
Nam, J,
Xu, Y,
Adams, D,
Lester, P,
Hetrick, T,
Schwendeman, A,
Wicha, MS,
Chang, AE,
Li, Q,
Moon, JJ,
Nano Lett, 2020 Oct; DOI:10.1021/acs.nanolett.0c03414 Financial and employment toxicity related to breast reconstruction following mastectomy in a diverse population-based cohort.
Berlin, NL,
Momoh, AO,
Abrahamse, P,
Katz, SJ,
Jagsi, R,
Hawley, ST,
Journal of Clinical Oncology, 2020 Oct; DOI:10.1200/jco.2020.38.29_suppl.78 Investigation of confocal microscopy for differentiation of renal cell carcinoma versus benign tissue. Can an optical biopsy be performed?
Phung, MC,
Rouse, AR,
Pangilinan, J,
Bell, RC,
Bracamonte, ER,
Mashi, S,
Gmitro, AF,
Lee, BR,
Asian J Urol, 2020 Oct; DOI:10.1016/j.ajur.2019.12.008 A multi-center phase II trial evaluating the efficacy of palbociclib in combination with carboplatin for the treatment of unresectable recurrent or metastatic head and neck squamous cell carcinoma
Swiecicki, PL,
Durm, G,
Bellile, E,
Bhangale, A,
Brenner, JC,
Worden, FP,
Invest New Drugs, 2020 Oct; DOI:10.1007/s10637-020-00898-2 Use of Cigarettes and E-Cigarettes/Vaping Among Transgender People: Results From the 2015 U.S. Transgender Survey
Kcomt, L,
Evans-Polce, RJ,
Veliz, PT,
Boyd, CJ,
McCabe, SE,
Am J Prev Med, 2020 Oct; DOI:10.1016/j.amepre.2020.03.027 